Impact of COVID-19 on Clinical Frailty Scale – a multicentre prospective cohort study.
S. Guler (Bern, Switzerland), I. Müller (Bern, Switzerland), M. Mancinetti (Fribourg, Switzerland), P. Bridevaux (Sion, Switzerland), M. Brutsche (St. Gallen, Switzerland), C. Clarenbach (Zürich, Switzerland), C. Garzoni (Lugano , Switzerland), A. Lenoir (Lausanne, Switzerland), B. Naccini (Lugano , Switzerland), S. Ott (Basel, Switzerland), L. Piquilloud (Lausanne, Switzerland), M. Prella (Lausanne, Switzerland), Y. Que (Lausanne, Switzerland), P. Soccal (Geneva, Switzerland), C. Von Garner (Lausanne, Switzerland), T. Geiser (Bern, Switzerland), M. Funke-Chambour (Bern, Switzerland)
Source: Virtual Congress 2021 – Chronic COVID - 19
Session: Chronic COVID - 19
Session type: Oral Presentation
Number: 84
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Guler (Bern, Switzerland), I. Müller (Bern, Switzerland), M. Mancinetti (Fribourg, Switzerland), P. Bridevaux (Sion, Switzerland), M. Brutsche (St. Gallen, Switzerland), C. Clarenbach (Zürich, Switzerland), C. Garzoni (Lugano , Switzerland), A. Lenoir (Lausanne, Switzerland), B. Naccini (Lugano , Switzerland), S. Ott (Basel, Switzerland), L. Piquilloud (Lausanne, Switzerland), M. Prella (Lausanne, Switzerland), Y. Que (Lausanne, Switzerland), P. Soccal (Geneva, Switzerland), C. Von Garner (Lausanne, Switzerland), T. Geiser (Bern, Switzerland), M. Funke-Chambour (Bern, Switzerland). Impact of COVID-19 on Clinical Frailty Scale – a multicentre prospective cohort study.. 84
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Clinical Assessment of Glycopyrronium in COPD phenotypes and ACOS: Prospective, case control, observational study Source: International Congress 2019 – COPD clinical trials: inhaled and oral therapies Year: 2019
Clinical characteristics, risk factors and outcomes in patients with severe COVID-19 registered in the International Severe Acute Respiratory and Emerging Infection Consortium WHO clinical characterisation protocol: a prospective, multinational, multicentre, observational study Source: ERJ Open Res, 8 (1) 00552-2021; 10.1183/23120541.00552-2021 Year: 2022
Patient-reported outcome measures after COVID-19: a prospective cohort study Source: Eur Respir J, 56 (5) 2003276; 10.1183/13993003.03276-2020 Year: 2020
Effectiveness of treatments for severe sepsis: a prospective multicentre observational study in Spanish ICUs Source: Annual Congress 2009 - Severe sepsis and multiple organ failure Year: 2009
Validation of the Sarcoidosis Diagnostic Score in a multinational study Source: International Congress 2019 – Granulomatous disorders: from bench to bedside Year: 2019
Asthma phenotypes in Turkey: A multicenter study Source: Annual Congress 2012 - Phenotypes and mechanisms of treatment of asthma Year: 2012
Risk factors for post-COVID-19 condition in previously hospitalised children using the ISARIC Global follow-up protocol: a prospective cohort study Source: Eur Respir J, 59 (2) 2101341; 10.1183/13993003.01341-2021 Year: 2022
Benefits of pulmonary rehabilitation in COVID-19 – a prospective observational cohort study Source: Virtual Congress 2021 – Insights into rehabilitation and physiotherapy in COVID-19 Year: 2021
An Italian, observational, multicenter trial in female COPD patients: Preliminary data on the women reality in the MISTRAL study Source: International Congress 2014 – Clinical assessment of airway diseases Year: 2014
Efficacy and safety of nintedanib in a Greek multicentre idiopathic pulmonary fibrosis registry: a retrospective, observational, cohort study Source: ERJ Open Res, 6 (1) 00172-2019; 10.1183/23120541.00172-2019 Year: 2020
Incidence and prevalence of Systemic Sclerosis-associated Interstitial Lung Disease in a multicenter prospective cohort study. Source: Virtual Congress 2020 – Addressing unresolved questions in rare diffuse parenchymal lung diseases: interdisciplinary research is the key Year: 2020
Assessment of the association between asthma and malignancy: a population-based retrospective matched cohort study Source: Annual Congress 2009 - Epidemiology of COPD and infectious lung diseases Year: 2009
Prospective cohort study of cured meat intake and asthma symptom score in the EGEA study Source: International Congress 2015 – New observations in respiratory epidemiology Year: 2015
Clinical, radiological and functional outcomes in patients with COVID-19 pneumonia: A prospective observational study Source: Virtual Congress 2021 – Imaging in COVID-19 Year: 2021
Late Breaking Abstract - 1-year radiological, functional and quality-of-life outcomes in patients with SARS-CoV-2 pneumonia: A prospective observational study. Source: Virtual Congress 2021 – Respiratory infections Year: 2021
Plasma levels of acute phase proteins in patients from the multicenter longitudinal French Cohort in Lung Transplantation (COLT): a pilot study Source: Virtual Congress 2020 – Treatments and biomarkers for lung allograft function and outcome Year: 2020
Etiology and clinical characteristics of bronchiectasis in Taiwan: a multi-center cohort study Source: International Congress 2019 – Tuberculosis epidemiology, bronchiectasis, other infections and spirometry Year: 2019
Protocol for the EARCO Registry: a pan-European observational study in patients with a1 -antitrypsin deficiency Source: ERJ Open Res, 6 (1) 00181-2019; 10.1183/23120541.00181-2019 Year: 2020
Characteristics of COPD patients from primary care enrolled in a prospective multicenter cohort study Source: Annual Congress 2010 - Comorbidity in obstructive airway disease Year: 2010
Late Breaking Abstract - Long-term safety of pirfenidone in a real-world setting: final results from the prospective, observational PASSPORT registry Source: International Congress 2017 – Late-breaking findings in pulmonary diseases Year: 2017